DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Invega (Paliperidone) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (18)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Invega side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Invega side effects in male

Reported by a physician from Denmark on 2012-06-25

Patient: male, weighing 85.0 kg (187.0 pounds)

Reactions: Hypersensitivity, Suffocation Feeling, Headache, Hypoaesthesia, Paraesthesia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Invega

Other drugs received by patient: Lyrica; Amisulprid; Seroquel; Propranolol



Possible Invega side effects in female

Reported by a physician from China on 2012-05-03

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Multiple Drug Overdose

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Clonazepam
    Dosage: uncounted tablets
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-08-13
    End date: 2011-08-13

Invega
    Administration route: Oral
    Indication: Schizophrenia

Invega
    Administration route: Oral
    Start date: 2011-08-13
    End date: 2011-08-13



Possible Invega side effects in female

Reported by a physician from China on 2012-05-01

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Multiple Drug Overdose

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Clonazepam
    Dosage: uncounted tablets
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-08-13
    End date: 2011-08-13

Invega
    Administration route: Oral
    Indication: Schizophrenia

Invega
    Administration route: Oral
    Start date: 2011-08-13
    End date: 2011-08-13



Possible Invega side effects in 27 year old female

Reported by a physician from Spain on 2012-04-23

Patient: 27 year old female

Reactions: Aspiration, Intentional Overdose, Drug Interaction, Depressed Level of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega

Other drugs received by patient possibly interacting with the suspect drug:
Akineton
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Clonazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Escitalopram
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Seroquel
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zyprexa
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Invega side effects in male

Reported by a physician from China on 2012-03-26

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Cardiac Arrest

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia

Propranolol Hydrochloride
    Administration route: Oral
    Indication: Tachycardia
    Start date: 2011-10-17

Other drugs received by patient: Benzhexol Hydrochloride; Alprazolam



Possible Invega side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-20

Patient: 21 year old male

Reactions: Neuroleptic Malignant Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Invega Sustenna
    Indication: Product Used FOR Unknown Indication
    End date: 2011-11-01

Strattera
    Indication: Product Used FOR Unknown Indication



Possible Invega side effects in male

Reported by a physician from China on 2012-02-15

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Cardiac Arrest

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia

Propranolol Hydrochloride
    Administration route: Oral
    Indication: Tachycardia
    Start date: 2011-10-17

Other drugs received by patient: Benzhexol Hydrochloride; Alprazolam



Possible Invega side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09

Patient: male, weighing 81.7 kg (179.6 pounds)

Reactions: Agitation, Psychomotor Hyperactivity, Hallucination, Auditory, Major Depression, Anger, Suicidal Ideation, Hunger

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Abilify
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-29

Invega Sustenna
    Start date: 2011-08-05
    End date: 2011-08-12

Invega Sustenna
    Indication: Schizoaffective Disorder
    Start date: 2011-07-29

Invega Sustenna
    Start date: 2011-08-05
    End date: 2011-08-12

Invega Sustenna
    Indication: Psychotic Disorder
    Start date: 2011-07-29

Other drugs received by patient: Risperdal; Cymbalta; Ambien; Cymbalta; Risperdal



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-27

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Adverse Event, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega

Other drugs received by patient: Seasonique



Possible Invega side effects in 42 year old male

Reported by a physician from Australia on 2012-01-20

Patient: 42 year old male

Reactions: Akathisia, Homicidal Ideation, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega



Possible Invega side effects in female

Reported by a physician from United States on 2012-01-19

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega

Other drugs received by patient: Seasonique



Possible Invega side effects in 42 year old male

Reported by a physician from Australia on 2012-01-18

Patient: 42 year old male

Reactions: Akathisia, Homicidal Ideation, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Invega



Possible Invega side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-12

Patient: male, weighing 81.7 kg (179.6 pounds)

Reactions: Agitation, Psychomotor Hyperactivity, Hallucination, Auditory, Major Depression, Anger, Suicidal Ideation, Hunger

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Abilify
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-29

Invega Sustenna
    Indication: Schizoaffective Disorder
    Start date: 2011-07-29

Invega Sustenna
    Start date: 2011-08-05
    End date: 2011-08-12

Invega Sustenna
    Indication: Psychotic Disorder
    Start date: 2011-07-29

Invega Sustenna
    Start date: 2011-08-05
    End date: 2011-08-12

Other drugs received by patient: Risperdal; Ambien; Cymbalta; Cymbalta; Risperdal



Possible Invega side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-09

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Electroencephalogram Abnormal, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Duloxetine Hydrochloride
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-11-15

Lithium Carbonate
    Indication: Product Used FOR Unknown Indication

Zolpidem Tartrate
    Indication: Product Used FOR Unknown Indication



Possible Invega side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-01

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Electroencephalogram Abnormal, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Duloxetine Hydrochloride
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-11-15

Lithium Carbonate
    Indication: Product Used FOR Unknown Indication

Zolpidem Tartrate
    Indication: Product Used FOR Unknown Indication

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017